ArticleCardiovascular diabetology2021

Sacubitril/valsartan inhibits obesity-associated diastolic dysfunction through suppression of ventricular-vascular stiffness.

Annayya R Aroor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.